DW-3102

· Daewon Pharmaceutical Co., Ltd.

Drug timelines are a Plus or Pro feature.

1 regulatory and trial event tracked for DW-3102, covering 2016-10-10 to 2016-10-10. Get the full timeline:

Most recent: Clinical Trial Update: A Clinical Trial for Evaluation of Adequate Dose and Safety of DW-3102 in Hypercholesterolemia Patients [Phase 2]